Press release
Traumatic Brain Injury Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Vasopharm GmbH, Pinteon Therapeutics, NeuroTrauma Sciences, Vasopharm, SanBio
"Traumatic Brain Injury Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Traumatic Brain Injury Therapeutics Market.
The report provides a detailed description of the Traumatic Brain Injury drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Traumatic Brain Injury Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/traumatic-brain-injury-tbi-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Traumatic Brain Injury Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Traumatic Brain Injury therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Traumatic Brain Injury treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Traumatic Brain Injury drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreements, and financing details for future advancement in the Traumatic Brain Injury treatment market.
Learn More about the Clinical and Commercial Development Activities in the Traumatic Brain Injury Therapeutics Domain @
https://www.delveinsight.com/report-store/traumatic-brain-injury-tbi-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Traumatic Brain Injury Therapeutics Analysis
There are no approved disease-specific treatment for TBI patients, although several new molecules are under investigation. Medications can help treat symptoms of TBI and lower the risk of some conditions associated with it. Some medications are useful immediately after a TBI, while others treat symptoms and problems related to recovery from TBI some time after the initial injury. These medications may include Anti-anxiety medication, Anticoagulants, Anticonvulsants, Antidepressants, Diuretics, Muscle relaxants, and Stimulants.
Since the treatment landscape is devoid of any effective curative treatment options, any significant development in this direction is expected to create a tectonic impact on the existing market scenario. Some of the drugs in the pipeline include VAS203 (Ronopterin) (Vasopharm GmbH), PNT001 (Pinteon Therapeutics), among others.
Traumatic Brain Injury Companies in the Therapeutics Market Include:
• Vasopharm GmbH
• Pinteon Therapeutics
• NeuroTrauma Sciences
• Vasopharm
• SanBio
And Many Others
Emerging and Marketed Traumatic Brain Injury Therapies Covered in the Report Include:
• VAS203 (Ronopterin): Vasopharm GmbH
• PNT001: Pinteon Therapeutics
• NTS-105: NeuroTrauma Sciences
• VAS203: Vasopharm
• Vandefitemcel: SanBio
And Many More
Get an in-depth Assessment of the Emerging Therapies and Traumatic Brain Injury Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/traumatic-brain-injury-tbi-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Traumatic Brain Injury Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates
Mechanism of Action of the Emerging Pipeline Therapies
• Progesterone receptor agonists
• Tau protein inhibitors
• Purinoceptor P2U agonists
• Nerve growth factor modulators
• Nitric oxide synthase inhibitors
• TrkB receptor agonists
Request for Sample PDF to Understand More About the Traumatic Brain Injury Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/traumatic-brain-injury-tbi-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Traumatic Brain Injury Current Treatment Patterns
4. Traumatic Brain Injury - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Traumatic Brain Injury Late-Stage Products (Phase-III)
7. Traumatic Brain Injury Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Traumatic Brain Injury Discontinued Products
13. Traumatic Brain Injury Product Profiles
14. Traumatic Brain Injury Companies
15. Traumatic Brain Injury Drugs
16. Dormant and Discontinued Products
17. Traumatic Brain Injury Unmet Needs
18. Traumatic Brain Injury Future Perspectives
19. Traumatic Brain Injury Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/traumatic-brain-injury-tbi-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research
Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices
Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology
Other Trending Healthcare Reports by DelveInsight
Tenosynovitis Market
https://www.delveinsight.com/report-store/tenosynovitis-market
Checkpoint Inhibitor Refractory Cancer Market
https://www.delveinsight.com/report-store/checkpoint-inhibitor-refractory-cancer-market
Encephalomyelitis Market
https://www.delveinsight.com/report-store/encephalomyelitis-market
FENEBRUTINIB Market
https://www.delveinsight.com/report-store/fenebrutinib-emerging-insight-and-market-forecast
Non-Muscle Invasive Bladder Cancer Market
https://www.delveinsight.com/report-store/non-muscle-invasive-bladder-cancer-market
Nrg1 Fusion Cancer Pipeline Insight
https://www.delveinsight.com/report-store/nrg1-fusion-cancer-pipeline-insight
Acute Pyelonephritis Market
https://www.delveinsight.com/report-store/acute-pyelonephritis-market
Chronic Refractory Gout Market
https://www.delveinsight.com/report-store/chronic-refractory-gout-market
Complicated Urinary Tract Infections Market
https://www.delveinsight.com/report-store/complicated-urinary-tract-infections-market
Congestive Heart Failure (CHF) Market
https://www.delveinsight.com/report-store/congestive-heart-failure-market
Glomerulonephritis Market
https://www.delveinsight.com/report-store/glomerulonephritis-market
Metastatic Uveal Melanoma (MUM) Market
https://www.delveinsight.com/report-store/metastatic-uveal-melanoma-mum-market
Musculoskeletal Pain Market
https://www.delveinsight.com/report-store/musculoskeletal-pain-market
Recurrent Head And Neck Cancer Squamous Cell Carcinoma Market
https://www.delveinsight.com/report-store/recurrent-head-and-neck-cancer-squamous-cell-carcinoma-market
Dysthymia Market
https://www.delveinsight.com/report-store/dysthymia-market
Limb Girdle Muscular Dystrophy (LGMD) Market
https://www.delveinsight.com/report-store/limb-girdle-muscular-dystrophy-lgmd-market
Lower-Limb Spasticity Market
https://www.delveinsight.com/report-store/lower-limb-spasticity-market
Hemiplegia Market
https://www.delveinsight.com/report-store/hemiplegia-market
Global Kinase Inhibitor in Autoimmune Diseases Market
https://www.delveinsight.com/report-store/global-kinase-inhibitor-in-autoimmune-diseases-market
Hereditary Spastic Paraplegias Market
https://www.delveinsight.com/report-store/hereditary-spastic-paraplegias-market
Amebiasis Market
https://www.delveinsight.com/report-store/amebiasis-market
Galactosemia Market
https://www.delveinsight.com/report-store/galactosemia-market
Generalized Pustular Psoriasis Market
https://www.delveinsight.com/report-store/generalized-pustular-psoriasis-market
Hepatic Impairment Market
https://www.delveinsight.com/report-store/hepatic-impairment-market
Tuberous Sclerosis Complex Market
https://www.delveinsight.com/report-store/tuberous-sclerosis-complex-market
Amyloidosis Market
https://www.delveinsight.com/report-store/amyloidosis-market
BRAF-Mutant Metastatic Melanoma Market
https://www.delveinsight.com/report-store/braf-mutant-metastatic-melanoma-market
Candidemia Market
https://www.delveinsight.com/report-store/candidemia-market
Hepatitis D Market
https://www.delveinsight.com/report-store/hepatitis-d-market
Hyperkalemia Market
https://www.delveinsight.com/report-store/hyperkalemia-market
Vasomotor symptoms (Hot flashes/Night sweats) Market
https://www.delveinsight.com/report-store/vasomotor-symptoms-market
Balloon Valvuloplasty Device Market
https://www.delveinsight.com/report-store/balloon-valvuloplasty-market
Choroideremia Market
https://www.delveinsight.com/report-store/choroideremia-market
Chronic Hand Eczema Market
https://www.delveinsight.com/report-store/chronic-hand-eczema-market
Complex Regional Pain Syndrome Market
https://www.delveinsight.com/report-store/complex-regional-pain-syndrome-crps-market
Diffuse Large B-cell Lymphoma Market
https://www.delveinsight.com/report-store/diffuse-large-b-cell-lymphoma-market
Hypersomnia Market
https://www.delveinsight.com/report-store/hypersomnia-market
Lamellar Ichthyosis (LI) Market
https://www.delveinsight.com/report-store/lamellar-ichthyosis-market
Ulcerative Colitis (UC) Market
https://www.delveinsight.com/report-store/ulcerative-colitis-uc-market
Vernal Keratoconjunctivitis Market
https://www.delveinsight.com/report-store/vernal-keratoconjunctivitis-market-insight
Endocarditis Market
https://www.delveinsight.com/report-store/endocarditis-market
Essential Thrombocythemia (ET) Market
https://www.delveinsight.com/report-store/essential-thrombocythemia-et-market-insights
Hepatorenal Syndrome Market
https://www.delveinsight.com/report-store/hepatorenal-syndrome-market
Pancreatic Ductal Carcinoma Market
https://www.delveinsight.com/report-store/pancreatic-ductal-carcinoma-market
Tenosynovial Giant Cell Tumors (TSGCTs) Market
https://www.delveinsight.com/report-store/tenosynovial-giant-cell-tumors-tsgcts-market
Trauma Fixation Devices Market
https://www.delveinsight.com/report-store/trauma-devices-market
Usher Syndrome Market
https://www.delveinsight.com/report-store/usher-syndrome-market
Vulvar Squamous Cell Carcinoma Market
https://www.delveinsight.com/report-store/vulvar-squamous-cell-carcinoma-market
Wide Neck Bifurcation Intracranial Aneurysms Market
https://www.delveinsight.com/report-store/wide-neck-bifurcation-intracranial-aneurysms-market
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Traumatic Brain Injury Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Vasopharm GmbH, Pinteon Therapeutics, NeuroTrauma Sciences, Vasopharm, SanBio here
News-ID: 3294340 • Views: 219
More Releases from DelveInsight Business Research LLP
Atopic Dermatitis Market to Witness Growth by 2032 | Amgen, Kyowa Kirin, Dermira …
DelveInsight's "Atopic Dermatitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Atopic Dermatitis, historical and forecasted epidemiology as well as the Atopic Dermatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Atopic Dermatitis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Atopic Dermatitis market size…
Adult T-cell Leukemia-Lymphoma Market to Witness Growth by 2032 | Novartis AG. M …
DelveInsight's "Adult T-cell Leukemia-Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Adult T-cell Leukemia-Lymphoma, historical and forecasted epidemiology as well as the Adult T-cell Leukemia-Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Adult T-cell Leukemia-Lymphoma market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted…
Adult-onset Growth Hormone Deficiency Market to Witness Growth by 2032 | Novo No …
DelveInsight's "Adult-onset Growth Hormone Deficiency Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Adult-onset Growth Hormone Deficiency, historical and forecasted epidemiology as well as the Adult-onset Growth Hormone Deficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Adult-onset Growth Hormone Deficiency market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and…
Ataxia Telangiectasia Market to Witness Growth by 2032 | Matrix Biomed, IntraBio …
DelveInsight's "Ataxia Telangiectasia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Ataxia Telangiectasia, historical and forecasted epidemiology as well as the Ataxia Telangiectasia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Ataxia Telangiectasia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Ataxia Telangiectasia market size…
More Releases for Traumatic
The increase in the prevalence of brain traumatic injuries is projected to boost …
The research report "Traumatic Brain Injury Treatment Market: By Treatment Type (Drugs, Surgery), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography - Global/Region/Country Forecast to 2028. The traumatic brain injury treatment market size was valued at USD 3.03 billion in 2021 is and anticipated to grow at 8.2% CAGR rate over the forecast period 2022-2028.
Glance our 200 slides market research and…
Global Traumatic Brain Injury Market - Forecasts to 2026
According to a new market research report published by Global Market Estimates, the Global Traumatic Brain Injury Market is projected to grow from USD 3.1 billion in 2021 to USD 4.5 billion by 2026 at CAGR of 8.0%. The increasing prevalence of traumatic brain injuries (TBIs), rising preference for minimally invasive procedures, and increasing awareness regarding early diagnosis of brain injuries are the major factors expected to fuel the market…
Traumatic Acid Market: Competitive Dynamics & Global Outlook 2025
LP INFORMATION recently released a research report on the Traumatic Acid analysis, which studies the Traumatic Acid industry coverage, current market competitive status, and market outlook and forecast by 2025.
Global “Traumatic Acid Market 2020-2025” Research Report categorizes the global Traumatic Acid by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players analysis, market share, growth rate, opportunities…
Chronic Traumatic Encephalopathy (CTE) - Pipeline Review, H2 2018 - ResearchByMa …
"Chronic Traumatic Encephalopathy (CTE) - Pipeline Review, H2 2018", provides an overview of the Chronic Traumatic Encephalopathy (CTE) (Central Nervous System) pipeline landscape.
Chronic Traumatic Encephalopathy (CTE) is a degenerative brain disease found in athletes, military veterans, and others with a history of repetitive brain trauma. Symptoms include loss of consciousness, headache, drowsiness, convulsions and slurred speech, nausea or vomiting and unusual behavior. Risk factors include repeated exposure to traumatic brain…
Traumatic Brain Injuries Treatment Market Intelligence with Competitive Landscap …
Each year traumatic brain injuries (TBI) contribute a substantial number of cases worldwide. TBI can be defined as an injury to the brain resulting from externally inflicted trauma resulting in damage to the brain cells and blood vessels. The signs and symptoms of TBI may appear soon after the head trauma or may sometimes take several days to weeks to appear. TBI can be categorized as mild, moderate and severe…
Traumatic Brain Injury - Pipeline Review, 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Traumatic Brain Injury - Pipeline Review, H1 2017, provides an overview of the Traumatic Brain Injury (Central Nervous System) pipeline landscape.
Traumatic brain injury happens when an external mechanical force causes brain damage. Traumatic brain injury usually results from a violent blow or jolt to the head or body. Symptoms include headache, dizziness, nausea or vomiting, mood changes, fatigue or drowsiness, difficulty sleeping…
